High throughput measurements, particularly next generation sequencing, provide powerful methods to measure the underlying causes of cancer. We frequently apply whole genome and transcriptome sequencing to define the specific molecular alterations that define different cancers and immunologic diseases.
Examples of work:
- Burkitt lymphoma
- Diffuse large B cell lymphoma
- Define the molecular features for rare cancers.
- Connect genetic alterations to clinical outcomes.